![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 9/08 | |
A61K 47/26 | |||
A61K 47/38 | |||
A61K 9/16 | |||
A61K 31/55 |
(11) | Number of the document | 2961383 |
(13) | Kind of document | T |
(96) | European patent application number | 14712793.0 |
Date of filing the European patent application | 2014-02-28 | |
(97) | Date of publication of the European application | 2016-01-06 |
(45) | Date of publication and mention of the grant of the patent | 2019-02-27 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/JP2014/055890 |
Date | 2014-02-28 |
(87) | Number | WO 2014/133196 |
Date | 2014-09-04 |
(30) | Number | Date | Country code |
2013041105 | 2013-03-01 | JP |
(72) |
AKAGI, Akitsuna, JP
SUZUKI, Kai, JP
NAKAMURA, Atsuya, JP
NISHIBAYASHI, Toru, JP
|
(73) |
Otsuka Pharmaceutical Co., Ltd.,
9, Kanda-Tsukasamachi 2-chome Chiyoda-ku, Tokyo 101-8535,
JP
|
(54) | SUSPENSION FOR ORAL ADMINISTRATION COMPRISING AMORPHOUS TOLVAPTAN |
SUSPENSION FOR ORAL ADMINISTRATION COMPRISING AMORPHOUS TOLVAPTAN |